MediWound (MDWD) Liabilities and Shareholders Equity (2016 - 2025)

MediWound's Liabilities and Shareholders Equity history runs 10 years deep, the most recent figure standing at $86.3 million for Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 17.36% year-over-year to $86.3 million; the TTM figure through Dec 2025 stood at $316.7 million (up 18.21% YoY), while the FY2025 annual figure was $86.3 million, up 17.36% from the prior year.
• Liabilities and Shareholders Equity was $86.3 million for Q4 2025 at MediWound, down from $94.4 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $94.4 million in Q3 2025 to a low of $19.7 million in Q4 2021.
• Historically, Liabilities and Shareholders Equity has averaged $53.8 million across 5 years, with a median of $63.4 million in 2023.
• The sharpest annual moves came in 2021 and 2023: Liabilities and Shareholders Equity sank 36.45% in 2021, then surged 204.97% in 2023.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $19.7 million in 2021, then jumped by 153.32% to $50.0 million in 2022, then soared by 32.88% to $66.5 million in 2023, then climbed by 10.59% to $73.5 million in 2024, then rose by 17.36% to $86.3 million in 2025.
• The last three Liabilities and Shareholders Equity figures came in at $86.3 million (Q4 2025), $94.4 million (Q3 2025), and $67.0 million (Q2 2025), per Business Quant data.